Related Experiment Video
Updated: May 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Progression of aortic pulse wave velocity in patients with chronic kidney disease
Susanne Tholen1, Katharina Klofat, Cheng Rui Pan
1Department of Nephrology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Insights
Arterial stiffness, measured by aortic pulse wave velocity (aPWV), significantly worsens in chronic kidney disease (CKD) patients over one year. Age, blood pressure, and diabetes accelerate this progression, highlighting cardiovascular risk factors in CKD.
Area of Science:
- Cardiovascular Physiology
- Nephrology
- Medical Science
Background:
- Aortic pulse wave velocity (aPWV) is elevated in chronic kidney disease (CKD) patients, indicating increased cardiovascular risk.
- The natural progression of arterial stiffness and its determinants in CKD patients are not fully understood.
Purpose of the Study:
- To investigate the progression of aPWV in CKD patients over 12 months.
- To identify factors associated with the acceleration of aPWV progression in this cohort.
Main Methods:
- aPWV was measured in 70 CKD patients at baseline and after 12 months.
- Correlations were analyzed between aPWV changes and variables including glomerular filtration rate reduction and diabetes mellitus.
- Patients were divided into stable and progressive aPWV groups to identify associated factors.
Main Results:
- aPWV significantly increased by 1.1 m/s in the cohort over 1 year (P<.01).
- Accelerated aPWV progression was associated with older age, higher systolic blood pressure, and diabetes mellitus.
- The rate of renal function decline (glomerular filtration rate reduction) did not significantly impact aPWV progression.
Conclusions:
- Annual aPWV progression in CKD patients averages 1 m/s, signifying heightened cardiovascular risk.
- Age, systolic blood pressure, and diabetes are key factors driving arterial stiffness progression in CKD.
- Further research is needed to evaluate variables contributing to progressive arterial stiffness in CKD.
Abstract:
Aortic pulse wave velocity (aPWV) is elevated in patients with chronic kidney disease (CKD) and predicts cardiovascular risk. However, the natural progression of arterial stiffness in these patients remains uncertain. Therefore, the main aim of this study was to investigate the development of aPWV and to identify potential factors associated with its progression. aPWV measurement was carried out in 70 CKD patients at baseline and after 12 months. Correlations to several variables, in particular annual glomerular filtration rate reduction and diabetes mellitus, were studied. In the cohort, aPWV significantly increased in 1 year by 1.1 m/s (P<.01). Dividing the group into patients with stable and progressive aPWV, factors associated with accelerated progression were age, systolic blood pressure, and diabetes, whereas loss of renal function had no significant impact. The annual aPWV progression in CKD patients reached 1 m/s, which predicts an increased cardiovascular risk. Variables involved with progressive arterial stiffness need further evaluation.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

